MarketLens

Is 10x Genomics' Latest Acquisition a Game-Changer for Proteomics

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is Bionano Genomics' Optical Genome Mapping a Game-Changer for Genetic Diagnostics

4 months ago

Is Coeur Mining's New Gold Acquisition a Game Changer for Investors

7 months ago

Is AeroVironment's Latest Robot a Game-Changer for AVAV Stock

3 months ago

Is Brookfield's $1.2 Billion World Freight Acquisition a Game Changer

3 months ago

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

10x Genomics won a patent infringement verdict against Parse Biosciences, a Qiagen subsidiary, after a Delaware jury found willful infringement of three patents licensed to Scale Biosciences. The verd...

QGEN

Stock News•3 weeks ago

Purdue innovation enhances multiomics workflow, eliminates sample preparation

Purdue University's patent-pending method eliminates sample preparation in multiomics workflows, a bottleneck consuming lab time and budget. The innovation is compatible with spatial analysis via LC-M...

Stock News•1 months ago

Alamar Biosciences: Promising But Expensive Proteomics Growth

Alamar Biosciences' ARGO platform converts instrument placements into recurring consumables demand, with consumables growing faster than instruments. Profitability of this growth remains unproven as t...

ALMR

Breaking News

Clinical Trials (Phase I, II, III)

Data Center Power Demand

Dividend Stocks

ETFs

Energy

Top Headlines

View More →

Stock News•5 hours ago

Forget Buying All Seven: The "Magnificent Seven" Stock Most Likely to Double by 2028

Stock News•6 hours ago

Google's Gemini is the latest AI model to hack other companies

Stock News•9 hours ago

Bill Ackman Said ‘Hell Is Coming' in 2020 — How a $27 Million Hedge Turned Into $2.6 Billion as He Bought the Crash

Stock News•9 hours ago

Warren Buffett Watched Alphabet's Stock Price Climb 9,000% Before He Decided to Invest. Here's Why He and Greg Abel Are Making It One of Berkshire Hathaway's Biggest Investments Now.

Stock News•10 hours ago

ALIBABA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Alibaba Group Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BABA

Is 10x Genomics' Latest Acquisition a Game-Changer for Proteomics

Exclusive Content for Pro Members

Related Articles

Is Bionano Genomics' Optical Genome Mapping a Game-Changer for Genetic Diagnostics

Is Coeur Mining's New Gold Acquisition a Game Changer for Investors

Is AeroVironment's Latest Robot a Game-Changer for AVAV Stock

Is Brookfield's $1.2 Billion World Freight Acquisition a Game Changer

Category

You may also like

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences

Purdue innovation enhances multiomics workflow, eliminates sample preparation

Alamar Biosciences: Promising But Expensive Proteomics Growth

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Forget Buying All Seven: The "Magnificent Seven" Stock Most Likely to Double by 2028

Google's Gemini is the latest AI model to hack other companies

Bill Ackman Said ‘Hell Is Coming' in 2020 — How a $27 Million Hedge Turned Into $2.6 Billion as He Bought the Crash

Warren Buffett Watched Alphabet's Stock Price Climb 9,000% Before He Decided to Invest. Here's Why He and Greg Abel Are Making It One of Berkshire Hathaway's Biggest Investments Now.

ALIBABA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Alibaba Group Holding Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BABA